Angiogenic Factors in Preeclampsia and Related Disorders
- 1Department of Medicine, Obstetrics & Gynecology, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02114; and Harvard Medical School, Boston, Massachusetts 02114
- 2Gulbenkian Programme for Advanced Medical Education, 1067-001 Lisbon, Portugal
- 3Howard Hughes Medical Institute, Chevy Chase, Maryland 20815
- Correspondence: sananth{at}bidmc.harvard.edu
Abstract
During fetal development, the human placenta undergoes high levels of both angiogenesis and vasculogenesis. Additionally, the developing placenta undergoes a process of vascular mimicry (referred to as pseudovasculogenesis) as cytotrophoblasts convert from an epithelial to an endothelial phenotype. The initiation, maturation, and maintenance of the placental vasculature are of critical importance. Failure to do so can lead to adverse obstetric outcomes such as preeclampsia and/or intrauterine growth restriction (IUGR). Furthermore, the foundation of many aspects of adult health is laid in utero. In this context, normal placental function is not only critical for normal fetal development but can also permanently influence long-term health and disease. Understanding the mechanisms that regulate placental vasculogenesis and angiogenesis is therefore of critical importance. This chapter will focus on placental vascular development with a particular emphasis on the role of angiogenic factors in the pathogenesis of the maternal syndrome of preeclampsia and related disorders.
- Copyright © 2012 Cold Spring Harbor Laboratory Press; all rights reserved